BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25659878)

  • 21. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.
    Salgia RJ; Goodrich NP; Simpson H; Merion RM; Sharma P
    Dig Dis Sci; 2014 Aug; 59(8):1976-82. PubMed ID: 24557576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
    Jose A; Shah SA; Anwar N; Jones CR; Sherman KE; Elwing JM
    Liver Transpl; 2021 Dec; 27(12):1811-1823. PubMed ID: 33964116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pulmonary complication of liver disease].
    Dollinger MM
    Praxis (Bern 1994); 2006 Oct; 95(40):1539-42. PubMed ID: 17048411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary hypertension in liver diseases].
    Savale L; Sattler C; Sitbon O
    Presse Med; 2014 Sep; 43(9):970-80. PubMed ID: 25148949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portopulmonary hypertension.
    Cartin-Ceba R; Krowka MJ
    Clin Liver Dis; 2014 May; 18(2):421-38. PubMed ID: 24679504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of portopulmonary hypertension among liver transplant candidates in a region highly endemic for viral hepatitis.
    Al-Harbi A; Abdullah K; Al-Abdulkareem A; Alghamdi A; Al-Jahdali H
    Ann Transplant; 2014 Jan; 19():1-5. PubMed ID: 24384535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portopulmonary hypertension.
    Nayak RP; Li D; Matuschak GM
    Curr Gastroenterol Rep; 2009 Feb; 11(1):56-63. PubMed ID: 19166660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portopulmonary hypertension.
    Al-Naamani N; Roberts KE
    Clin Chest Med; 2013 Dec; 34(4):719-37. PubMed ID: 24267301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience.
    Ogawa E; Hori T; Doi H; Segawa H; Uemoto S
    Clin Transplant; 2014 Sep; 28(9):1031-40. PubMed ID: 24986560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary vascular abnormalities in cirrhosis.
    Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
    Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension.
    Raevens S; Geerts A; Devisscher L; Van Vlierberghe H; Van Steenkiste C; Colle I
    Acta Gastroenterol Belg; 2021; 84(1):95-99. PubMed ID: 33639700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects of portopulmonary hypertension.
    Medarov BI; Chopra A; Judson MA
    Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portopulmonary hypertension and hepatopulmonary syndrome.
    Aldenkortt F; Aldenkortt M; Caviezel L; Waeber JL; Weber A; Schiffer E
    World J Gastroenterol; 2014 Jul; 20(25):8072-81. PubMed ID: 25009379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary complications in chronic liver disease.
    Machicao VI; Balakrishnan M; Fallon MB
    Hepatology; 2014 Apr; 59(4):1627-37. PubMed ID: 24089295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portopulmonary hypertension: survival and prognostic factors.
    Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O
    Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portopulmonary hypertension.
    Barua UK; Hossain AS; Roy GC; Rahman MA; Das M
    Mymensingh Med J; 2013 Jul; 22(3):618-24. PubMed ID: 23982562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study.
    Shao Y; Yin X; Qin T; Zhang R; Zhang Y; Wen X
    Biomed Res Int; 2021; 2021():5595614. PubMed ID: 33987440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
    Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic options in pulmonary hepatic vascular diseases.
    Horvatits T; Fuhrmann V
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):31-42. PubMed ID: 24308785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.